CNSP
CNS Pharmaceuticals Inc
NASDAQ: CNSP · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.44% today
Updated 2026-04-30
Market cap
$1.91M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-35.75
Dividend yield
—
52W range
$2 – $17
Volume
0.0M
CNS Pharmaceuticals Inc (CNSP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-112197.00 | $-716385.00 | $-3.55M | $-7.32M | $-13.54M | $-10.56M | $-14.14M | $-17.11M | $-13.81M |
| Capital expenditures | $3.00 | $5.00 | $20120.00 | $17945.00 | $5748.00 | $4422.00 | $3901.00 | $4188.00 | $18175.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $119854.00 | $110240.00 | $477096.00 | $1.29M | $1.72M | $1.20M | $1.01M | $838957.00 | $187728.00 |
| Free cash flow | $-112200.00 | $-716390.00 | $-3.57M | $-7.34M | $-13.54M | $-10.56M | $-14.14M | $-17.12M | $-13.83M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $6.80M | — | — | — | — | — |